Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 16/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL5859572 | 0.98 | ACHE (0.50) | ACHECHRM3CHRM4CHRM2 | |
| SCHEMBL10265915 | 0.87 | ACHE (0.52) | ACHECHRM3CHRM4 | |
| SCHEMBL12160731 | 0.83 | ACHE (0.48) | ACHECHRM3 | |
| SCHEMBL5859581 | 0.79 | ACHE (0.47) | ACHE | |
| SCHEMBL17069874 | 0.79 | CHRM3 (0.45) | ACHECHRM3CHRM2 | |
| SCHEMBL15610575 | 0.79 | CHRM3 (0.47) | ACHECHRM3CHRM2 | |
| SCHEMBL10256418 | 0.79 | CHRM3 (0.50) | ACHECHRM3CHRM2 | |
| SCHEMBL3681307 | 0.75 | CHRNA7 (0.60) | ACHECHRM3CHRM4CHRM2 | |
| SCHEMBL24105554 | 0.75 | CHRNA7 (0.40) | ACHECHRM3 | |
| SCHEMBL724930 | 0.74 | CHRNB2 (0.61) | CHRM3CHRM4CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1010667-B1 | Stannosilicate molecular sieves having the zeolite beta structure | UOP LLC (US) | 2003-10-08 | — | — | EP | claimed |
| US-10875780-B2 | Synthesis of nanocrystalline beta zeolite, synthesis method and use thereof in catalytic applications | UNIVERSITAT POLITECNICA DE VALENCIA (ES) | 2020-12-29 | — | — | US | disclosed |
| US-20200216326-A1 | Synthesis of Nanocrystalline Beta Zeolite, Synthesis Method and use Thereof in Catalytic Applications | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2020-07-09 | — | — | US | disclosed |
| EP-3636595-A1 | SYNTHESIS OF NANOCRYSTALLINE BETA ZEOLITE, SYNTHESIS METHOD AND USE THEREOF IN CATALYTIC APPLICATIONS | Universitat Politècnica de València (ES) | 2020-04-15 | — | — | EP | disclosed |
| EP-2518042-B1 | PRODUCTION OF MYRTANAL FROM BETA-PINENE EPOXIDE | CONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS CSIC (ES) | 2018-03-28 | — | — | EP | disclosed |
| US-20150353518-A1 | CATALYST AND CATALYTIC PROCESS FOR THE ETHERIFICATION/REDUCTION OF FURFURYL DERIVATIVES TO TETRAHYDROFURFURYL ETHERS | UNIVERSITAT POLITECNICA DE VALENCIA (ES) | 2015-12-10 | — | — | US | disclosed |
| EP-2913328-A1 | CATALYST AND CATALYTIC PROCESS FOR THE ETHERIFICATION/REDUCTION OF FURFURYL DERIVATIVES TO TETRAHYDROFURFURYL ETHERS | Consejo Superior De Investigaciones Científicas (CSIC) (ES) | 2015-09-02 | — | — | EP | disclosed |
| US-8633338-B2 | Production of myrtanal from beta-pinene epoxide | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2014-01-21 | — | — | US | disclosed |
| US-20120330065-A1 | PRODUCTION OF MYRTANAL FROM BETA-PINENE EPOXIDE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2012-12-27 | — | — | US | disclosed |
| EP-2518042-A1 | PRODUCTION OF MYRTANAL FROM BETA-PINENE EPOXIDE | Consejo Superior De Investigaciones Científicas (CSIC) (ES) | 2012-10-31 | — | — | EP | disclosed |
| US-7087779-B2 | Aldehyde conversion method using a molecular sieve and the use of the molecular sieve as a catalyst in said method | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2006-08-08 | — | — | US | disclosed |
| US-20050113604-A1 | Aldehyde conversion method using a molecular sieve and the use of the molecular sieve as a catalyst in said method | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2005-05-26 | — | — | US | disclosed |
| EP-1489065-A1 | ALDEHYDE CONVERSION METHOD USING A MOLECULAR SIEVE AND THE USE OF THE MOLECULAR SIEVE AS A CATALYST IN SAID METHOD | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003064363-A1 | METHOD FOR THE PREPARATION OF AN AROMATIC ALDEHYDE | RHODIA CHIMIE (FR) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353518-A1 | CATALYST AND CATALYTIC PROCESS FOR THE ETHERIFICATION/REDUCTION OF FURFURYL DERIVATIVES TO TETRAHYDROFURFURYL ETHERS | ADH1A, ADH1C, ADH5 | ACHE 1803/4885CHRM3 4824/4885CHRM4 4306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.